SNYR (synergychc.com) Net Profit

Corporate emblem and logo of Synergy CHC Corp (SNYR)

Production line optimization minimizes costs for Synergy CHC Corp. The holding company is scaling its beauty brands via marketplaces, while revenue is driven by sales of dietary supplements and natural cosmetics to loyal customers. The visualization of the company's profit on the GURU.Markets consolidated chart confirms financial stability, while the -0.02 level captures the latest values of the key metric.

SNYR (synergychc.com) Company Net Income history from 10/24/2024 to 10/03/2026

Financial and market metric breakdowns for synergychc.com (SNYR)

- price and consensus price forecast:
Stock Quotes Synergy CHC|SNYR - Analyst Consensus Forecast
- business market valuation indicators:
Market Capitalization Synergy CHC Corp.|SNYR - Real Price to Acquire Entire Company
- book capitalization data:
Accounting Value of a Share Synergy CHC|SNYR - Company Book Value|Market-to-Book Ratio synergychc.com|SNYR - Cumulative Company Assets
- debt and solvency information:
Aggregate Debt to Capital Synergy CHC Corp|SNYR - Long-Term Debt to Capital|Ratio of Short-Term Indebtedness to Capital Synergy CHC|SNYR - Company Aggregate Debts|Debts to Book Value Synergy CHC Corp.|SNYR - Company Long-Term Debt|Company Short-Term Loans and Borrowings Synergy CHC|Interim Coverage Ratio synergychc.com
- net income and valuation multiples indicators:
SNYR - Net Income
Fundamental valuation:SNYR Synergy CHC Corporation
Flagship merchandise of Synergy CHC Corp.

To identify fundamental sector leaders, analysts evaluate net income, which accumulates daily profit minus all expenses to determine the real value of a business. At Synergy CHC Corp (SNYR), this metric reflects the efficiency of fulfillment automation and supply chain optimization, allowing investors to use the company's profit trend on GURU.Markets to identify asset rebalancing points in a timely manner.

Main competitors

Net Income Haleon Corp|KVUE (Kenvue Inc.) - Net Profit|Net Profit veronapharma.com|Net Income MENS (Jyong Biotech)|LGND (Ligand Pharmaceuticals Incorporated) - Final Profit|Company Net Income Amneal Pharmaceuticals Inc AMRX|Perrigo Corp (PRGO) - Company Net Income|ALVO: Net Income|liquidia.com - Profit After Payment of Taxes|GLPG: Net Profit|ANI Pharmaceuticals Inc - Final Profit|MNKD (MannKind Corp.) - Net Profit|Company Net Income Amphastar Corp AMPH|Company Net Income Pacira BioSciences (PCRX)|SPRY (ars-pharma.com) - Final Profit|Company Net Income Theravance Biopharma, Inc. TBPH|Net Financial Result Aquestive Therapeutics Inc (AQST)|SCPH: Net Income|Company Net Income Tectonic Therapeutic, Inc.|Tonix Pharmaceuticals (TNXP) - Company Net Income|Company Profit SXTC|EPRX (Eupraxia Pharmaceuticals, Inc.) - Net Profit|Company Net Income BioHarvest Sciences, Inc. BHST|Company Net Income Invizyne Technologies, Inc. (EXOZ)|ORMP (oramed.com) - Final Profit|Net Profit ENTX (Entera Bio)|Annual Net Income ipatherapeutics.com|ABVC: Net Income|Company Net Income Cumberland Pharmaceuticals Inc|QNTM (Quantum BioPharma Limited) - Net Income|FibroGen Corporation - Final Profit|TELO (Telomir Pharmaceuticals) - Net Profit|Net Income Rani Therapeutics Inc (RANI)|Net Profit RLYB|LEXX (lexariabioscience.com) - Final Profit|Net Profit PULM (Pulmatrix Corp)|PTHL - Net Income|APM: Net Income|Final Profit LYRA (lyratherapeutics.com)|IBO: Net Profit|Net Income TNF Pharmaceuticals, Inc.|Company Net Income cbdMD Inc.|Company Net Income PainReform Corp PRFX|Company Net Income Altamira Therapeutics (CYTO)|LIPO (lipella.com) - Final Profit|Company Net Income OptiNose OPTN|PIRS (Pieris Pharmaceuticals Inc) - Profit After Tax|PROC - Company Net Income|Net Financial Result Petros Pharma PTPI|Qilian International (QLI) - Company Net Income|Company Profit SLRN|Net Income TFFP